Northern Trust
PAND

Northern Trust’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Northern Trust’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-124,148
Closed -$7.46M – 4686
2021
Q1 		$7.46M Buy
124,148
+33,069
+36% +$1.2M ﹤0.01% 2486
2020
Q4 		$1.35M Buy
91,079
+138
+0.2% +$1.92K ﹤0.01% 3388
2020
Q3 		$1.04M Buy
+90,941
New +$1.55M ﹤0.01% 3376

Northern Trust's PAND Position: Q2 2021 in Review

Northern Trust sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 124,148 shares — an estimated $7.46M sold.

Northern Trust first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $7.46M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Northern Trust reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Northern Trust sold 124,148 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $7.46M.
  • Northern Trust first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Northern Trust's Pandion Therapeutics Inc. Common Stock position peaked at $7.46M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.